Björklund Pharma strategically invests in and operates healthcare ventures, including specialized clinical services. With a strong commitment to scientific innovation and patient-centered care, the company balances direct ownership of key strategic investments alongside minority stakes that complement its product development efforts. This integrated approach fosters sustainable growth and advances holistic treatment solutions for complex conditions such as autism spectrum disorder and ADHD.